Keywords: promising, initial, ph, ii, data, ascenta, at-101

Promising initial Ph II data on Ascenta's AT-101

Article | 09 March 2009

Print This

The USA's Ascenta Therapeutics reported positive preliminary results from a Phase II study of AT-101 in combination with docetaxel and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in